Published in Gene Therapy Weekly, August 2nd, 2007
David L. Parker, Ph.D, J.D., Introgen's senior vice president of Intellectual Property, commented, "This patent is a significant addition to Introgen's...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.